By Scientia Professor Gregory John Dore

Journal articles

Matthews G; Bartholomeusz A; Locarnini S; Ayres A; Sasaduesz J; Seaberg E; Cooper DA; Lewin S; Dore GJ; Thio C, 2006, 'Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy', AIDS, 20, pp. 863 - 870

Dore GJ; Cooper DA, 2006, 'HAART`s first decade: success brings further challenges', Lancet, 368, pp. 427 - 428

Smith BJ; Bauman A; Loveday S; Costello M; Mackie B; Dore GJ; Chen J, 2006, 'Hepatitis C in Australia: impact of a mass media campaign', American Journal of Preventive Medicine, 31, pp. 492 - 498, http://dx.doi.org/10.1016/j.amepre.2006.08.001

Dore GJ; Guan R; Jafri SM; Sarin S; Keeffe E, 2006, 'Management of chronic hepatitis B in challenging patient populations.', Liver International, 26, pp. 38 - 46

Roberts S; Cooksley G; Dore GJ; Robson RA; Shaw DW; Berns H; Brandl M; Fettner S; Hill G; Ipe D; Klumpp K; Mannino M; O Mara E; Tu Y; Washington C, 2006, 'Results of a phase 1B, multiple dose study of R1626, a novel nucleoside analog targeting HCV polymerase in chronic HCV genotype 1 patients', Hepatology, 44, pp. 692A - 692A

Micallef JM; Kaldor JM; Dore GJ, 2006, 'Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies', Journal of Viral Hepatitis, 13, pp. 34 - 41

Thein H; Butler T; Krahn M; Rawlinson WD; Levy M; Kaldor JM; Dore GJ; Butler , 2006, 'The effect of hepatitis C virus infection on health-related quality of life in prisoners', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 83, pp. 275 - 288

Amin J; Law MG; O Connell DL; Bartlett M; Tracey E; Kaldor JM; Dore GJ, 2005, 'Cancer incidence in people with hepatitis B or C infection: A population based cohort study', Journal of Hepatology, 42, pp. 88 - 88

Thein H; Krahn M; Kaldor JM; Dore GJ, 2005, 'Estimation of utilities for chronic hepatitis C from SF-36 scores', American Journal of Gastroenterology, 100, pp. 643 - 651

Hallinan R; Byrne A; Amin J; Dore GJ, 2005, 'Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy', Journal of Gastroenterology and Hepatology, 20, pp. 1082 - 1086

Duncombe CJ; Kerr SJ; Ruxrungtham K; Dore GJ; Law MG; Emery S; Lange J; Phanuphak P; Cooper DA, 2005, 'HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting', AIDS, 19, pp. 169 - 178

Doab AE; Treloar C; Dore GJ, 2005, 'Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia', Clinical Infectious Diseases, 40, pp. S313 - S320

Dore GJ; Thomas DL, 2005, 'Management and treatment of injection drug users with hepatitis C virus(HCV) infection and HCV/human immunodeficiency virus coinfection', Seminars in Liver Disease, 25, pp. 18 - 32

Jin F; Prestage G; Kippax SC; Kaldor JM; Dore GJ; Grulich AE, 2005, 'Prevalence and risk factors of hepatitis C in HIV-negative homosexual men in Sydney, Australia', Australian and New Zealand Journal of Public Health, 29, pp. 536 - 539

Stoove M; Gifford S; Dore GJ, 2005, 'The impact of injecting drug use status on hepatitis C-related referral and treatment', Drug and Alcohol Dependence, 77, pp. 81 - 86, http://www.sciencedirect.com/science/article/B6T63-4D99DYG-1/2/42ceb60f2196a4dcc220b7c3ec818c86

Matthews G; Kronborg I; Dore GJ, 2005, 'Treatment for hepatitis C virus infection among current injection drug users in Australia', Clinical Infectious Diseases, 40, pp. S325 - S329

Dore GJ, 2004, 'Editorial comment: Triple infection with HIV and hepatitis B and C viruses - Lesson in combination therapy', AIDS Reader, 14, pp. 392

Jauncey ME; Micallef JM; Gilmour S; Amin J; White PA; Rawlinson WD; Kaldor JM; Van Beek IA; Dore GJ, 2004, 'Clearance of hepatitis C virus after newly acquired infection ininjection drug users', Journal of Infectious Diseases, 190, pp. 1270 - 1274

Dore GJ; Cooper DA; Pozniak A; DeJesus E; Zhong L; Miller MD; Lu B; Cheng A, 2004, 'Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus', Journal of Infectious Diseases, 189, pp. 1185 - 1192

O Sullivan BG; Gidding H; Law MG; Kaldor JM; Gilbert GL; Dore GJ, 2004, 'Estimates of chronic hepatitis B virus infection in Australia, 2000', Australian and New Zealand Journal of Public Health, 28, pp. 212 - 216

O'Sullivan BG; Gidding HF; Law M; Kaldor JM; Gilbert GL; Dore GJ, 2004, 'Estimates of chronic hepatitis B virus infection in Australia, 2000', Australian and New Zealand Journal of Public Health, 28, pp. 212 - 216, http://dx.doi.org/10.1111/j.1467-842x.2004.tb00477.x

Hutin Y; Kitler M; Dore GJ; Perz J; Armstrong G; Dusheiko G; Ishibashi H; Grob P; Kew M; Marcellin P; Seeff L; Beutels P; Nelson CJ; Stein C; Zurn P; Clifford G; Vranckx R; Alberti A; Hallaj Z; Hadler S; Lavanchy D, 2004, 'Global burden of disease (GBD) for hepatitis C', Journal of Clinical Pharmacology, 44, pp. 20 - 29

Amin J; Gidding HF; Gilbert GL; Backhouse J; Kaldor JM; Dore GJ; Burgess MA, 2004, 'Hepatitis C prevalence - a nationwide serosurvey', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 28, pp. 517 - 521

Hallinan R; Amin J; Dore GJ, 2004, 'Hepatitis C virus incidence among injecting drug users on opioid replacement therapy', Australian and New Zealand Journal of Public Health, 28, pp. 576 - 578

Amin J; Kaye M; Skidmore S; Pillay D; Cooper DA; Dore GJ, 2004, 'HIV and hepatitis C coinfection within the CAESAR study', HIV Medicine, 5, pp. 174 - 179

Law WP; Duncombe CJ; Mahanontharit A; Boyd MA; Ruxrungtham K; Lange JM; Phanuphak P; Cooper DA; Dore GJ, 2004, 'Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort', AIDS, 18, pp. 1169 - 1177

Rerksuppaphol S; Hardikar W; Dore GJ, 2004, 'Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children', Journal of Gastroenterology and Hepatology, 19, pp. 1357 - 1362

Qasabian R; Meagher AP; Lee RW; Dore GJ; Keogh AM, 2004, 'Severe diverticulitis after heart, lung, and heart-lung transplantation', Journal of Heart and Lung Transplantation, 23, pp. 845 - 849

Robotin M; Copland J; Tallis G; Coleman D; Giele C; Carter L; Spencer J; Kaldor JM; Dore GJ, 2004, 'Surveillance for newly acquired hepatitis C in Australia', Journal of Gastroenterology and Hepatology, 19, pp. 283 - 288

Matthews G; Dore G, 2003, 'Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: We must target the virus or liver fibrosis?' [3]', AIDS, 17, pp. 2675 - 2676

Dore GJ; Thein HH, 2003, 'Cost-effectiveness of treatment for chronic hepatitis C infection', JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 290, pp. 1993 - 1993, http://dx.doi.org/10.1001/jama.290.15.1993-b

Bernstein D; Dore GJ; Thein HH; Salomon JA; Goldie SJ, 2003, 'Cost-effectiveness of Treatment for Chronic Hepatitis C Infection [2] (multiple letters)', JAMA, 290, pp. 1993 - 1994, http://dx.doi.org/10.1001/jama.290.15.1993-a

Dore G, 2003, 'Antiretroviral therapy-related hepatotoxicity: predictors and clinical management.', Journal of HIV therapy, 8, pp. 96 - 100

Dore GJ; MacDonald M; Law MG; Kaldor JM, 2003, 'Epidemiology of hepatitis C virus infection in Australia.', Australian family physician, 32, pp. 796 - 798

Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM, 2003, 'Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok', Southeast Asian Journal of Tropical Medicine and Public Health, 34, pp. 804 - 809

Thein HH; Haber PS; Dore GJ, 2003, 'Quality of life of women living with hepatitis C', Journal of Gastroenterology and Hepatology (Australia), 18, pp. 1329 - 1331, http://dx.doi.org/10.1046/j.1440-1746.2003.03216.x

MICALLEF J; JAUNCEY M; AMIN J; RAWLINSON W; GILMOUR S; VANBEEK I; KALDOR J; WHITE P; DORE G, 2003, '229 Hepatitis C virus reinfection within a cohort of injecting drug users', Hepatology, 38, pp. 266 - 266, http://dx.doi.org/10.1016/s0270-9139(03)80272-0

Thompson S; Boughton CR; Dore GJ, 2003, 'Blood-borne viruses and their survival in the environment: is publicconcern about community needlestick exposures justified?', Australian and New Zealand Journal of Public Health, 27, pp. 602 - 607

Dore GJ, 2003, 'Clinical management of HIV/viral Hepatitis coinfection', Journal of Clinical Virology, 28, pp. S43 - S43

Dore GJ, 2003, 'Cost-effectiveness of treatment for chronic hepatitis C infection', Journal of the American Medical Association, 290, pp. 1933 - 1934

MacDonald MA; Law MG; Kaldor JM; Hales J; Dore GJ, 2003, 'Effectiveness of needle and syringe programmes for preventing HIV transmission', International Journal of Drug Policy, 14, pp. 353 - 357

Dore GJ; Law MG; MacDonald MA; Kaldor JM, 2003, 'Epidemiology of hepatitis C virus infection in Australia', Journal of Clinical Virology, 26, pp. 171 - 184

Lincoln DW; Petoumenos K; Dore GJ, 2003, 'HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy', HIV Medicine, 4, pp. 241 - 249

Thein H; Denoe M; Van Beek IA; Dore GJ; MacDonald MA, 2003, 'Injecting behaviour of injecting drug users at needle and syringe programs and pharmacies in Australia', International Journal of Drug Policy, 14, pp. 425 - 430

McDonald AM; Li Y; Dore GJ; Ree H; Kaldor JM, 2003, 'Late HIV presentation among AIDS cases in Australia, 1992-2001', Australian and New Zealand Journal of Public Health, 27, pp. 608 - 613

Dore GJ; McDonald AM; Li Y; Kaldor JM; Brew BJ, 2003, 'Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, 17, pp. 1539 - 1545

Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor JM; Loveday S; Powell E; Spencer J; Wodak AD, 2003, 'Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001', International Journal of Epidemiology, 32, pp. 717 - 724

Dore GJ; Freeman A; Law MG; Kaldor JM, 2003, 'Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings', Antiviral Therapy, 8, pp. 365 - 372

Freeman A; Law MG; Kaldor JM; Dore GJ, 2003, 'Predicting progression to cirrhosis in chronic hepatitis C virus infection', Journal of Viral Hepatitis, 10, pp. 285 - 293

Thein H; Haber P; Dore GJ, 2003, 'Quality of life among women with hepatitis C (editorial)', Journal of Gastroenterology and Hepatology, 18, pp. 1329 - 1331

Back to profile page